10 Results for "

Gatekeeper mutations

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "Gatekeeper mutations" in MCE Product Catalog:

Cat. No.: HY-12291
CAS No.: 1315329-43-1
Purity:  99.69%
Synonyms: HMSL 10017-101-1
Target:  

Raf Apoptosis

Research Areas:  

Cancer

HG6-64-1 (HMSL 10017-101-1) is a B-raf kinase modulator.HG6-64-1 modulates B-raf kinase activity, including the V600E mutant form and the drug-resistant gatekeeper mutation T529I. HG6-64-1 is a germinal center kinase inhibitor. HG6-64-1 induces cell cycle arrest and apoptosis. HG6-64-1 can be used for the research of diffuse large B-cell lymphoma (DLBCL) .
loading...
    loading...
Cat. No.: HY-139590
CAS No.: 2216753-97-6
Purity:  98.31%
Synonyms: BOS-172738; DS-5010
Target:  

RET PDGFR

Research Areas:  

Cancer

Zeteletinib (BOS-172738; DS-5010) is an orally active, selective RET kinase inhibitor with nanomolar potency against RET and >300-fold selectivity against VEGFR2. Zeteletinib shows exquisite potency for the wild type RET, RET V804M/L gatekeeper mutants, and the most common oncogenic RET mutation M918T. Zeteletinib has potent antitumor activity .
loading...
    loading...
Cat. No.: HY-15814
CAS No.: 1258391-13-7
Purity:  99.94%
Research Areas:  

Cancer

HG-7-85-01 is a type II ATP competitive inhibitor of wild-type and gatekeeper mutations forms of Bcr-Abl, PDGFRα, Kit, and Src kinases. HG-7-85-01 inhibits T315I mutant Bcr-Abl kinase, KDR and RET with IC50s of 3 nM, 20 nM and 30 nM, and is only weak or no inhibition of other kinases (IC50>2 μM). HG-7-85-01 inhibits the cell proliferation, which is mediated by the induction of apoptosis, and inhibition of cell-cycle progression .
loading...
    loading...
Cat. No.: HY-W005118
CAS No.: 944401-77-8
Synonyms: 4-Fluoropyridin-2-amine
2-Amino-4-fluoropyridine (4-Fluoropyridin-2-amine) is a drug intermediate that can be used for the synthesis reversible-covalent FGFR4 inhibitors .
loading...
    loading...
Cat. No.: HY-139590A
CAS No.: 2375837-06-0
Synonyms: BOS-172738 hemiadipate; DS-5010 hemiadipate
Target:  

RET PDGFR

Research Areas:  

Cancer

Zeteletinib (BOS-172738; DS-5010) hemiadipate is an orally active, selective RET kinase inhibitor with nanomolar potency against RET and >300-fold selectivity against VEGFR2. Zeteletinib hemiadipate shows exquisite potency for the wild type RET, RET V804M/L gatekeeper mutants, and the most common oncogenic RET mutation M918T. Zeteletinib hemiadipate has potent antitumor activity .
loading...
    loading...
Cat. No.: HY-134301A
Synonyms: 8-Ethylthio-NAD+ sodium
Target:  

PARP

Research Areas:  

Cancer

8-ET-NAD+ (sodium) is the derivative of NAD+. 8-ET-NAD+ (sodium) can be used in screening of PARP1 gatekeeper mutations. 8-ET-NAD+ (sodium) can be studied in research on cancer .
loading...
    loading...
Cat. No.: HY-160478
CAS No.: 839708-29-1
Target:  

Bcr-Abl

Research Areas:  

Cancer

GNF-6 (Compound 14) inhibits the gatekeeper threonine residue mutation of BCR-ABL-T315I with IC50s of 0.25 μM, 0.09 μM and 0.590 μM for c-ABL-T334I, BCR-ABL and BCR-ABL-T315I variants, respectively. GNF-6, an ATP competitive inhibitor, disrupts the assembly of the hydrophobic spine (a network of hydrophobic interactions), thereby locking the kinase in an inactive ‘DFG-out’ conformation .
loading...
    loading...
Cat. No.: HY-E70717
Target:  

FGFR

Research Areas:  

Cancer

FGFR1 has been implicated in numerous cancer types including non-small cell lung cancer (NSCLC). FGFR1 is activated upon FGF binding to its extracellular domain, resulting in protein dimerization and transautophosphorylation of the intracellular tyrosine kinase domains. FGFR1 V561M gatekeeper mutation drives Fexagratinib (AZD4547) (HY-13330) resistance through STAT3 Activation and EMT. FGFR1 V561M Recombinant Human Active Protein Kinase is a recombinant FGFR1 V561M protein that can be used to study FGFR1 V561M-related functions .
loading...
    loading...
Cat. No.: HY-134300A
Synonyms: 8-Dimethylamino-NAD+ sodium
Target:  

Endogenous Metabolite

Research Areas:  

Others

8-DMA-NAD+ (sodium) (8-Dimethylamino-NAD+ (sodium)) is a derivative of the signaling molecule and enzyme cofactor NAD+ (HY-B0445). 8-DMA-NAD+ (sodium) can be used in the screening of analog-sensitive poly (ADP-ribose) polymerase 1 (PARP1) gatekeeper mutations .
loading...
    loading...
Cat. No.: HY-134305A
Synonyms: 8-Methylamino-NAD+ sodium
Target:  

Endogenous Metabolite

Research Areas:  

Others

8-MA-NAD+ (sodium) (8-Methylamino-NAD+ (sodium)) is a derivative of the signaling molecule and enzyme cofactor NAD+ (HY-B0445). 8-MA-NAD+ (sodium) can be used in the screening of analog-sensitive poly (ADP-ribose) polymerase 1 (PARP1) gatekeeper mutations. 8-MA-NAD+ (sodium) can be used in the synthesis of cyclic ADP-ribose (cADPR) derivatives .
loading...
    loading...